Papers
3
Total Citations
89
H-Index
3
About
Carlo Ronsini is a leading figure in gynecologic oncology and minimally invasive surgery, whose work is reshaping surgical standards for complex pelvic malignancies. His primary research focuses on optimizing perioperative outcomes for ovarian and endometrial cancers, particularly through the integration of robotic and laparoscopic techniques. Ronsini’s most influential study, a 2014 retrospective cohort with 64 citations, demonstrated that minimally invasive secondary cytoreduction combined with HIPEC offers comparable safety to open surgery for isolated ovarian cancer relapse—a finding that has informed clinical decision-making for recurrent disease. He has also advanced the field of robotic surgery: his 2023 systematic review on robotic single-site hysterectomy for benign pathology (17 citations) established this approach as a safe, less invasive alternative to traditional laparoscopy. More recently, his 2025 network meta-analysis (8 citations) provided critical evidence on the safety and efficacy of robotic, laparoscopic, and open surgery in severely obese endometrial cancer patients, addressing a high-risk population often excluded from trials. Through these contributions, Ronsini has not only expanded the evidence base for minimally invasive techniques but also improved surgical outcomes for patients with challenging presentations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3